A Blood Biomarker for Alzheimer’s Disease
Neurofilament light chain levels could indicate familial Alzheimer’s disease 22 years before onset
Luke Turner | | Quick Read
Neurofilament light chain (NfL) – a previously identified potential biomarker of neurodegeneration – could be an early indicator of Alzheimer's disease. A new study, carried out by a team from Harvard Medical School and Massachusetts General Hospital, set out to determine NfL’s efficacy as a biomarker for Alzheimer’s and the earliest age at which plasma NfL levels distinguish individuals at high risk of the disease.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.